Revisiting Timing and Decision Modeling for Allogeneic Hematopoietic Stem-Cell Transplantation in Myelodysplastic Syndromes

被引：1

作者：

Cutler, Corey ^{[1
]}

机构：

[1] Harvard Med Sch, Dana Farber Canc Inst, Div Transplantat & Cellular Therapy, Boston, MA 02215 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 24期

关键词：

PROGNOSTIC SCORING SYSTEM; BIOLOGIC-ASSIGNMENT; DONOR AVAILABILITY; ELDERLY-PATIENTS; OLDER PATIENTS; VALIDATION; MUTATIONS; IMPACT; AGE;

D O I：

10.1200/JCO.24.00649

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The Oncology Grand Rounds series is designed to place original reports published in the Journal into clinical context. A case presentation is followed by a description of diagnostic and management challenges, a review of the relevant literature, and a summary of the authors' suggested management approaches. The goal of this series is to help readers better understand how to apply the results of key studies, including those published in Journal of Clinical Oncology, to patients seen in their own clinical practice. Decision Theory and the IPSS-M - New #HCT guidance in #MDS - and a comment on the new @CMS coverage Decision memo

引用

页码：2843 / 2848

页数：7

共 41 条

[1]

Abel GA, 2021, LEUKEMIA, V35, P1223, DOI 10.1038/s41375-021-01138-z

[2] Optimal timing of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndrome [J].

Alessandrino, Emilio Paolo ;

Della Porta, Matteo G. ;

Malcovati, Luca ;

Jackson, Christopher H. ;

Pascutto, Cristiana ;

Bacigalupo, Andrea ;

van Lint, Maria Teresa ;

Falda, Michele ;

Bernardi, Massimo ;

Onida, Francesco ;

Guidi, Stefano ;

Iori, Anna Paola ;

Cerretti, Raffaella ;

Marenco, Paola ;

Pioltelli, Pietro ;

Angelucci, Emanuele ;

Oneto, Rosi ;

Ripamonti, Francesco ;

Rambaldi, Alessandro ;

Bosi, Alberto ;

Cazzola, Mario ;

Levis, A. ;

Rambaldi, A. ;

Bandini, G. ;

Casini, M. ;

Rossi, G. ;

Angelucci, E. ;

Baronciani, D. ;

La Nasa, G. ;

Milone, G. ;

Mordini, N. ;

Guidi, S. ;

Bosi, A. ;

Bacigalupo, A. ;

Van Lint, M. T. ;

Corradini, P. ;

Milani, R. ;

Morra, E. ;

Marenco, P. ;

Deliliers, G. Lambertenghi ;

Onida, F. ;

Ciceri, F. ;

Bernardi, M. ;

Castagna, L. ;

Narni, F. ;

Pioltelli, P. ;

Selleri, Carmine ;

Scime, R. ;

Iannitto, E. ;

Musso, M. .

AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (07) :581-588

[3] The Composite Health Risk Assessment Model (CHARM) to Predict 1-Year Non-Relapse Mortality (NRM) Among Older Recipients of Allogeneic Transplantation: A Prospective BMT-CTN Study 1704 [J].

Artz, Andrew ;

Logan, Brent R. ;

Saber, Wael ;

Geller, Nancy ;

Bellach, Anna ;

Kou, Jianqun ;

Wood, William ;

McCarty, John M. ;

Knight, Thomas G. ;

Runaas, Lyndsey ;

Johnston, Laura ;

Walston, Jeremy ;

Nakamura, Ryotaro ;

Schuler, Tammy ;

Mishra, Asmita ;

Uberti, Joseph ;

Dahi, Parastoo B. ;

Saultz, Jennifer N. ;

McCurdy, Shannon R. ;

Morris, Lawrence ;

Imus, Philip ;

Hogan, William J. ;

Nadiminti, Kalyan ;

Bhatt, Vijaya Raj ;

Mattila, Deborah ;

Protz, Bailey ;

Devine, Steven M. ;

Horowitz, Mary M. ;

Sorror, Mohamed .

BLOOD, 2023, 142

[4] Comparison of Patient Age Groups in Transplantation for Myelodysplastic Syndrome The Medicare Coverage With Evidence Development Study [J].

Atallah, Ehab ;

Logan, Brent ;

Chen, Min ;

Cutler, Corey ;

Deeg, Joachim ;

Jacoby, Meagan ;

Champlin, Richard ;

Nishihori, Taiga ;

Confer, Dennis ;

Gajewski, James ;

Farnia, Stephanie ;

Greenberg, Peter ;

Warlick, Erica ;

Weisdorf, Daniel ;

Saber, Wael ;

Horowitz, Mary M. ;

Rizzo, J. Douglas .

JAMA ONCOLOGY, 2020, 6 (04) :486-493

[5] What's Next after Hypomethylating Agents Failure in Myeloid Neoplasms? A Rational Approach [J].

Awada, Hussein ;

Gurnari, Carmelo ;

Xie, Zhuoer ;

Bewersdorf, Jan Philipp ;

Zeidan, Amer M. .

CANCERS, 2023, 15 (08)

[6] Risk prediction in MDS: independent validation of the IPSS-M-ready for routine? [J].

Baer, Constance ;

Huber, Sandra ;

Hutter, Stephan ;

Meggendorfer, Manja ;

Nadarajah, Niroshan ;

Walter, Wencke ;

Platzbecker, Uwe ;

Goetze, Katharina S. ;

Kern, Wolfgang ;

Haferlach, Torsten ;

Hoermann, Gregor ;

Haferlach, Claudia .

LEUKEMIA, 2023, 37 (04) :938-941

[7] Clinical Effect of Point Mutations in Myelodysplastic Syndromes [J].

Bejar, Rafael ;

Stevenson, Kristen ;

Abdel-Wahab, Omar ;

Galili, Naomi ;

Nilsson, Bjoern ;

Garcia-Manero, Guillermo ;

Kantarjian, Hagop ;

Raza, Azra ;

Levine, Ross L. ;

Neuberg, Donna ;

Ebert, Benjamin L. .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (26) :2496-2506

[8]

Bernard E, 2022, NEJM EVID, V1, DOI 10.1056/EVIDoa2200008

[9] Implications ofTP53allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes [J].

Bernard, Elsa ;

Nannya, Yasuhito ;

Hasserjian, Robert P. ;

Devlin, Sean M. ;

Tuechler, Heinz ;

Medina-Martinez, Juan S. ;

Yoshizato, Tetsuichi ;

Shiozawa, Yusuke ;

Saiki, Ryunosuke ;

Malcovati, Luca ;

Levine, Max F. ;

Arango, Juan E. ;

Zhou, Yangyu ;

Sole, Francesc ;

Cargo, Catherine A. ;

Haase, Detlef ;

Creignou, Maria ;

Germing, Ulrich ;

Zhang, Yanming ;

Gundem, Gunes ;

Sarian, Araxe ;

van de Loosdrecht, Arjan A. ;

Jadersten, Martin ;

Tobiasson, Magnus ;

Kosmider, Olivier ;

Follo, Matilde Y. ;

Thol, Felicitas ;

Pinheiro, Ronald F. ;

Santini, Valeria ;

Kotsianidis, Ioannis ;

Boultwood, Jacqueline ;

Santos, Fabio P. S. ;

Schanz, Julie ;

Kasahara, Senji ;

Ishikawa, Takayuki ;

Tsurumi, Hisashi ;

Takaori-Kondo, Akifumi ;

Kiguchi, Toru ;

Polprasert, Chantana ;

Bennett, John M. ;

Klimek, Virginia M. ;

Savona, Michael R. ;

Belickova, Monika ;

Ganster, Christina ;

Palomo, Laura ;

Sanz, Guillermo ;

Ades, Lionel ;

Della Porta, Matteo Giovanni ;

Smith, Alexandra G. ;

Werner, Yesenia .

NATURE MEDICINE, 2020, 26 (10) :1549-+

[10]

CALR, Clinical and genomic-based Decision Support System to define the optimal timing of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndromes

← 1 2 3 4 5 →